Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 6/20 | 0.62 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.62 |
| ▸ | CHRNB4 | P30926 | 5/20 | 0.62 |
| ▸ | CHRNA3 | P32297 | 5/20 | 0.62 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.62 |
| ▸ | CHRNA2 | Q15822 | 3/20 | 0.62 |
| ▸ | CHRNG | P07510 | 2/20 | 0.62 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.62 |
| ▸ | CHRND | Q07001 | 2/20 | 0.62 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.56 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | HTR3B | O95264 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17264284 | 1.00 | CHRNB2 (0.62) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL3058805 | 1.00 | CHRNB2 (0.62) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL20164036 | 0.93 | CHRNB4 (0.56) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL17258323 | 0.83 | CHRNB4 (0.46) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL30866535 | 0.82 | CHRNB4 (0.64) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL159159 | 0.82 | CHRNB4 (0.64) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL31019621 | 0.82 | CHRNB4 (0.64) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL159158 | 0.82 | CHRNB4 (0.64) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| Nornicotine SCHEMBL21082930 | 0.81 | CHRNA7 (0.60) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 | |
| SCHEMBL1538366 | 0.81 | CHRNB4 (0.62) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100260671-A1 | COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AMYLOID ASSOCIATED DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-10-14 | — | — | US | claimed |
| WO-2008151073-A1 | COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AMYLOID ASSOCIATED DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-12-11 | — | — | WO | claimed |
| CN-113373188-A | Synthesis method of (S) -nicotine | 重庆博腾制药科技股份有限公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-105143216-B | Antibacterial bis-aromatic derivative | 爱杜西亚药品有限公司 | 2018-04-13 | — | — | CN | disclosed |
| EP-3143012-A1 | CONJUGATES AND ASSOCIATED METHODS OF PRODUCING THEM FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | Pfizer Inc. (US) | 2017-03-22 | — | — | EP | disclosed |
| US-9475793-B2 | Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction | PFIZER INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-9475793-B2 | Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction | PFIZER INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-9475793-B2 | Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction | PFIZER INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-20160176846-A1 | CONJUGATES AND ASSOCIATED METHODS OF PRODUCING THEM FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | PFIZER (US) | 2016-06-23 | — | — | US | disclosed |
| US-20160176846-A1 | CONJUGATES AND ASSOCIATED METHODS OF PRODUCING THEM FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | PFIZER (US) | 2016-06-23 | — | — | US | disclosed |
| US-20160176846-A1 | CONJUGATES AND ASSOCIATED METHODS OF PRODUCING THEM FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | PFIZER (US) | 2016-06-23 | — | — | US | disclosed |
| EP-0739342-A1 | PYRIDINE MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| WO-1996015123-A1 | PYRIDINE MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| EP-0708633-A1 | SURFACTANT SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| WO-1995018206-A1 | PEROXYACID BLEACH PRECURSOR PARTICLE COATED WITH A WATER SOLUBLE ORGANIC ACID IN PARTICULATE FORM | THE PROCTER & GAMBLE COMPANY (US) | 1995-07-06 | — | — | WO | disclosed |
| WO-1995002390-A1 | SURFACTANT SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 1995-01-26 | — | — | WO | disclosed |
| EP-0559495-A1 | Treatment of neurodegenerative diseases | R.J. REYNOLDS TOBACCO COMPANY (US) | 1993-09-08 | — | — | EP | disclosed |
| EP-0559495-A1 | Treatment of neurodegenerative diseases | R.J. REYNOLDS TOBACCO COMPANY (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5242935-A | Alzheimer*s disease, compounds with a pyridine and a pyrrole ring | R. J. REYNOLDS TOBACCO COMPANY (US) | 1993-09-07 | — | — | US | disclosed |
| US-5242935-A | Alzheimer*s disease, compounds with a pyridine and a pyrrole ring | R. J. REYNOLDS TOBACCO COMPANY (US) | 1993-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100260671-A1 | COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AMYLOID ASSOCIATED DISEASES | APP, HTT, SCN3A | CHRNB2 19/4885CHRNA4 31/4885CHRNB4 25/4885 |
| US-20160176846-A1 | CONJUGATES AND ASSOCIATED METHODS OF PRODUCING THEM FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | NNMT, CHAT, CES2 | CHRNB2 10/4885CHRNA4 37/4885CHRNB4 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.